Rockwell Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rockwell Medical generated cash of -$9,412,000, which is more than the previous year. Cash used in financing activities reached the amount of $11,342,000 last year. Net change in cash is therefore -$1,119,000.
Cash Flow
| 2014 | 4.25M | -8.80M | 58.46M |
|---|---|---|---|
| 2015 | -16.24M | -21.14M | 2.78M |
| 2016 | -12.45M | -1.64M | 80.16K |
| 2017 | -21.11M | 14.50M | -2.16M |
| 2018 | -20.41M | 12.72M | 22.00M |
| 2019 | -27.25M | -4.74M | 21.08M |
| 2020 | -29.64M | 3.21M | 63.31M |
| 2021 | -33.53M | 311K | -2.17M |
| 2022 | -17.41M | -2.39M | 16.63M |
| 2023 | -9.41M | -3.04M | 11.34M |
RMTI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.10M | 13.28M | 48.68M | 11.79M | 22.71M | 8.40M | 17.18M | 31.19M | 65.80M | 11.88M |
Operating activities | ||||||||||
Net income | -8.43M | -18.67M | -32.67M | -30.89M | -34.12M | -32.12M | -25.92M | -19.80M | -14.42M | -21.32M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.44M | 2.58M | 2.51M | 2.28M | 2.65M | 650.14K | 514.36K | 762.36K | 822.29K | 996.32K |
Stock-based compensation expense | 932K | 315K | 943K | 475K | 4.95M | 0 | 7.17M | 10.34M | 8.88M | 10.09M |
| Deferred income tax benefit | 932K | 315K | 943K | 475K | 4.95M | 0 | 7.17M | 10.34M | 8.88M | 10.09M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -4.64M | -346K | -1.74M | 32K | 2.77M | -623.94K | -962.33K | -1.16M | -574.73K | 106.31K |
Inventories | 1.17M | -2.10M | -656K | -1.30M | 316.87K | -835.64K | 343.49K | -6.09M | -3.95M | -1.12M |
Accounts payable | 463K | 314K | -416K | 1.13M | -1.47M | 269.91K | -1.63M | 1.86M | -1.29M | -3.39M |
Cash generated by operating activities | -9.41M | -17.41M | -33.53M | -29.64M | -27.25M | -20.41M | -21.11M | -12.45M | -16.24M | 4.25M |
Investing activities | ||||||||||
Purchases Of Investments | -5.70M | -21.29M | -26.05M | -29.30M | -41.67M | -20.17M | -35.73M | -25.78M | -21.8M | -13.1M |
Investments In Property Plant And Equipment | -284K | -281K | -522K | -1.04M | -1.33M | -994.25K | -1.68M | -355.26K | -815.00K | -684.59K |
Acquisitions Net | -12.36M | 2.11M | -833K | -4.25M | 750K | -250K | 725 | 1K | 4.8K | 0 |
Cash generated by investing activities | -3.04M | -2.39M | 311K | 3.21M | -4.74M | 12.72M | 14.50M | -1.64M | -21.14M | -8.80M |
Financing activities | ||||||||||
Common Stock Issued | 14.86M | 15.01M | 107K | 42.94M | 24.16M | 22M | 123.60K | 80.16K | 2.78M | 79.56M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -6K | -19K | -279K | 0 | -2.28M | 0 | -2.91M | 0 |
Repayments of term debt | -3.51M | -13.19M | -2.28M | -22.5M | -1.14M | 0 | 0 | 0 | 0 | -21.1M |
Cash used in financing activities | 11.34M | 16.63M | -2.17M | 63.31M | 21.08M | 22.00M | -2.16M | 80.16K | 2.78M | 58.46M |
Net Change In Cash | -1.11M | -3.17M | -35.40M | 36.88M | -10.91M | 14.30M | -8.77M | -14.01M | -34.60M | 53.91M |
Cash at end of period | 8.98M | 10.10M | 13.28M | 48.68M | 11.79M | 22.71M | 8.40M | 17.18M | 31.19M | 65.80M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |